So the drug companies' $1.32 billion estimate was off, according to Light and Warburton, by only $977 million. Let's call it a rounding error.
A simple little decision brings an important reminder
-
The Davies v Lazer Safe decision is a timely reminder that in IP disputes,
leverage often sits in the procedural details. The Court clarified that an
old f...
4 days ago

No comments:
Post a Comment